Single B Cell-Based Monoclonal Antibody Development Service

Service Overview

Single B cell antibody technology enables the direct isolation of antigen-specific B cells from immunized animals, followed by amplification and recovery of native antibody variable region sequences. Compared with traditional hybridoma methods, this approach shortens the discovery timeline and provides direct access to naturally paired heavy and light chain sequences without the need for cell fusion.

At AbTriva, our single B cell-based monoclonal antibody development service is designed for projects requiring high-affinity antibody discovery, difficult antigen targeting, or rapid sequence recovery workflows. This platform is particularly useful for antigens that are unstable in hybridoma screening or require precise epitope targeting.

We integrate antigen preparation, immunization, B cell isolation, single-cell screening, VH/VL amplification, recombinant expression, and functional validation into a streamlined discovery pipeline.

When to Use Single B Cell Antibody Discovery

This platform is especially suitable for:

• Low-immunogenicity or conserved protein targets
• Membrane proteins and GPCR extracellular domains
• Conformation-sensitive or unstable epitopes
• Fast antibody discovery timelines
• Projects requiring direct antibody sequence recovery
• Antibodies intended for recombinant production from the start

For standard screening-heavy workflows or large clone libraries, hybridoma-based approaches may still be preferred depending on project design.

Workflow Overview

Our single B cell antibody discovery workflow is built around rapid identification of antigen-specific B cells and direct antibody gene recovery.

Step 1 — Antigen Preparation & Immunization

Recombinant protein or peptide antigen design

Rabbit or mouse immunization

Serum titer monitoring

Immune response evaluation

Step 2 — Antigen-Specific B Cell Enrichment

PBMC or splenocyte isolation

Antigen-specific B cell labeling

FACS or magnetic enrichment

Memory B cell enrichment

Step 3 — Single B Cell Screening

Single-cell deposition

ELISA or fluorescence-based screening

Positive clone identification

Step 4 — VH/VL Amplification & Sequencing

Single-cell RT-PCR

Native heavy/light chain recovery

Sequence validation

Pairing confirmation

Step 5 — Recombinant Expression

HEK293 or CHO expression

Protein A/G purification

Milligram-scale antibody production

Step 6 — Functional Validation

ELISA

Western Blot

Immunofluorescence

Immunohistochemistry

Flow Cytometry

Optional SPR/BLI affinity analysis

Deliverables

Depending on project scope, typical deliverables include:

• Verified VH/VL antibody sequences
• Recombinant monoclonal antibodies (mg scale)
• Binding validation data (ELISA / WB / FC / IHC)
• Sequence annotation report
• Expression and purification report
• Optional epitope or affinity characterization (SPR/BLI)

Key Advantages of Single B Cell Technology

1. Direct access to native antibody sequences

No hybridoma fusion step is required, reducing artifacts introduced by cell fusion instability.

2. Faster discovery timeline

Early sequence recovery enables earlier recombinant expression and optimization.

3. High diversity recovery

Improved likelihood of capturing rare high-affinity clones.

4. Recombinant-first workflow compatibility

Sequences are immediately compatible with downstream engineering and production.

Comparison: Single B Cell vs Hybridoma

Technical Considerations & Limitations

Single B cell discovery is highly sensitive to immune response quality and sorting efficiency. The following factors may affect success rate:

• Weak immunogenic response to target antigen
• Poor B cell enrichment efficiency
• Conformation-dependent epitopes difficult to present in screening format
• Low frequency of antigen-specific B cells in circulation

We evaluate antigen design and immunization strategy prior to project initiation to determine feasibility and optimize expected outcomes.

Applications

Single B cell-derived monoclonal antibodies are widely used in:

• Immunohistochemistry (IHC / IF)
• Flow cytometry assay development
• ELISA and sandwich assay design
• Neutralization and blocking studies
• Biomarker validation
• Diagnostic antibody development
• Recombinant antibody engineering pipelines

Project Start & Consultation

We recommend early-stage discussion of:

• Target antigen type and species
• Desired downstream application (IHC, FC, ELISA, etc.)
• Affinity and specificity requirements
• Timeline constraints
• Preference for rabbit vs mouse immune systems

Our scientific team will evaluate feasibility and propose a customized discovery strategy aligned with your research goals.

Why Choose AbTriva

• Integrated immunization and antibody discovery platform
• Native VH/VL sequence recovery
• Recombinant antibody production from the beginning
• Flexible rabbit and mouse workflows
• Experienced support for challenging antigens
• Multiple downstream validation options

Start Your Single B Cell Antibody Discovery Project

Accelerate your antibody discovery program with AbTriva's integrated single B cell platform.

Getting Started

• Submit your antigen sequence or protein information
• Receive a complimentary feasibility assessment
• Obtain a customized project proposal
• Select the optimal antibody discovery workflow

Typical response time: 1–2 business days